Therefore, the purpose of this study was to assess the relations between both serum FGF-21 and Visfatin with the obesity and its metabolic disorders, and their use as potential predictors for metabolic risk factors in a sample of Egyptian obese and non-obese children. This evidence concerns the gene NAMPT and metabolic disease.